These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10596854)

  • 1. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
    Joseph K; Shibayama Y; Nakazawa Y; Peerschke EI; Ghebrehiwet B; Kaplan AP
    Immunopharmacology; 1999 Sep; 43(2-3):203-10. PubMed ID: 10596854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
    Joseph K; Ghebrehiwet B; Kaplan AP
    Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the plasma kinin forming cascade along cell surfaces.
    Kaplan AP; Joseph K; Shibayama Y; Reddigari S; Ghebrehiwet B
    Int Arch Allergy Immunol; 2001; 124(1-3):339-42. PubMed ID: 11307009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
    Joseph K; Tholanikunnel BG; Kaplan AP
    Int Immunopharmacol; 2002 Dec; 2(13-14):1851-9. PubMed ID: 12489799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
    Nakazawa Y; Joseph K; Kaplan AP
    Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of high molecular weight kininogen binding proteins on endothelial cells.
    Joseph K; Tholanikunnel BG; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2004 Jan; 91(1):61-70. PubMed ID: 14691569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP; Natesan S; Joseph K; Kaplan AP
    Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of bradykinin: a major contributor to the innate inflammatory response.
    Joseph K; Kaplan AP
    Adv Immunol; 2005; 86():159-208. PubMed ID: 15705422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells.
    Mahdi F; Shariat-Madar Z; Todd RF; Figueroa CD; Schmaier AH
    Blood; 2001 Apr; 97(8):2342-50. PubMed ID: 11290596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
    Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW
    Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes.
    Mahdi F; Madar ZS; Figueroa CD; Schmaier AH
    Blood; 2002 May; 99(10):3585-96. PubMed ID: 11986212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.
    Shibayama Y; Joseph K; Nakazawa Y; Ghebreihiwet B; Peerschke EI; Kaplan AP
    Clin Immunol; 1999 Jan; 90(1):89-99. PubMed ID: 9884356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
    Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells.
    Fernando LP; Fernando AN; Joseph K; Kaplan AP
    J Thromb Haemost; 2003 Nov; 1(11):2444-9. PubMed ID: 14629481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
    Mahdi F; Shariat-Madar Z; Schmaier AH
    J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
    Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.